Skip to content
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
Biogen
Eli Lilly’s stock has swum on Alzheimer’s drug developments. What investors need to know.
ViGeneron, Biogen to develop AAV-based gene therapies for eye disease